Content area
Doc number: 725
Abstract
Background: Large scale transcript analysis of human glomerular microvascular endothelial cells (HGMEC) has never been accomplished. We designed this study to define the transcriptome of HGMEC and facilitate a better characterization of these endothelial cells with unique features. Serial analysis of gene expression (SAGE) was used for its unbiased approach to quantitative acquisition of transcripts.
Results: We generated a HGMEC SAGE library consisting of 68,987 transcript tags. Then taking advantage of large public databases and advanced bioinformatics we compared the HGMEC SAGE library with a SAGE library of non-cultured ex vivo human glomeruli (44,334 tags) which contained endothelial cells. The 823 tags common to both which would have the potential to be expressed in vivo were subsequently checked against 822,008 tags from 16 non-glomerular endothelial SAGE libraries. This resulted in 268 transcript tags differentially overexpressed in HGMEC compared to non-glomerular endothelia. These tags were filtered using a set of criteria: never before shown in kidney or any type of endothelial cell, absent in all nephron regions except the glomerulus, more highly expressed than statistically expected in HGMEC. Neurogranin, a direct target of thyroid hormone action which had been thought to be brain specific and never shown in endothelial cells before, fulfilled these criteria. Its expression in glomerular endothelium in vitro and in vivo was then verified by real-time-PCR, sequencing and immunohistochemistry.
Conclusions: Our results represent an extensive molecular characterization of HGMEC beyond a mere database, underline the endothelial heterogeneity, and propose neurogranin as a potential link in the kidney-thyroid axis.
Author details 1-Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer Guertel 18 - 20, A-1090 Vienna, Austria
2-Center for Integrative Bioinformatics Vienna, Max F. Perutz Laboratories, Medical University of Vienna/University of Vienna, Dr. Bohr-Gasse 9, A-1030 Vienna, Austria
3-EMBL, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
4-Department of Physiology, Medical University of Innsbruck, Christoph-Probst-Platz 1, Innrain 52, A-6020 Innsbruck, Austria
5-Department of Haematology and Oncology, Elisabethinen Hospital, Fadingerstraße 1, A-4020 Linz, Austria
6-London Research Institute, Lincoln's Inn Fields Laboratories, Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3LY, UK
Title: Human and rodent genomics
Background
Endothelial cells (EC) are frequently thought to be homogenous because of the multiple functions they share independent of the organ they serve, such as providing a non-thrombogenic surface, regulation of production or inhibition of vasoactive substances, haemostasis as well as leukocyte recruitment. Yet on closer examination, they show significant heterogeneity between similar vessels in different organ systems or in arterial versus venous endothelia [1-5]. Although known as highly specialized cells since the description of their fenestrated phenotype by F. Jorgensen more than 40 years ago [6] glomerular endothelial characteristics remain largely undefined.
Global gene expression studies added large amounts of valuable information to our knowledge on various EC and related pathologies, e.g. atherosclerosis [7]. Yet, in the case of human glomerular microvascular endothelial cells (HGMEC) developments did not have comparable pace. Due to challenges in obtaining, culturing and maintaining HGMEC studies employing primary cells in human glomerular research have been scarce, but very useful in obtaining new insights of human glomerular endothelium; most recently Amaral et al. investigated how Shiga toxin type-2 and Subtilase cytotoxin lead to damages characteristic for haemolytic uremic syndrome [8]. The ultimate aim to experiment with non-cultured glomerular EC has never been attained and the very first human glomerular endothelial cell line (GEnC) was not presented until 2006 [9]. This cell line has proved to be a useful tool in kidney research. Recently, glomerular endothelial barrier function and its regulation were finally studied in great detail using this tool while previously filtration barrier function research has mostly been on podocytes and the contribution of the glomerular endothelium had been relatively neglected [10]. These studies showed how reactive oxygen species present in common pathologies such as diabetes cause glomerular injury by directly disrupting glycocalyx and how chondroitin sulphate controlled by vascular growth factors A and C contributes to glomerular endothelial glycocalyx modulating the protein passage [8-11]. Nevertheless, despite its usefulness in endothelial research an immortalized cell line is not suitable to define the cellular transcriptome with its predominant and specific transcripts. Thus, we hypothesized that such an investigation using genetically unmodified HGMEC would enhance our understanding regarding the source of the unique morphological characteristics, the behaviour in both culture and in disease and prepare the grounds for further studies of HGMEC. We used serial analysis of gene expression (SAGE), because it provides an unbiased approach to gene discovery and enables quantitative acquisition of most transcripts expressed [12]. Secondly, SAGE has become a powerful tool due to creation of large datasets holding more than two hundred million tags from a wide spectrum of tissues or cells including different EC which are publicly available as part of the Cancer Genome Anatomy Project [13].
The goals of this study were to establish extensive transcriptomic data as a step towards identification of the transcripts controlling the distinctive morphological and functional characteristics of glomerular endothelium and to underline endothelial diversity by comparisons between SAGE libraries from glomerular endothelial and uncultured glomeruli or from other non-glomerular EC. To reach these goals based on the known challenge in receiving useful data out of large transcript lists we describe a research strategy powerful enough to first confirm the endothelial origin of the transcript lists by bioinformatics, then to identify a low abundant transcript, neurogranin (NRGN) for the first time in glomerular endothelium using an in-silico analysis and finally to verify its expression in vitro and in vivo by means of sequencing and immunohistochemistry.
Results
Characterisation of HGMEC
Primary HGMEC formed monolayers and displayed typical cobblestone morphology (Figure [figure omitted; refer to PDF] A) in phase contrast microscopy. Immunofluorescence studies revealed distinct expression of von Willebrand Factor (vWF) and platelet/endothelial cell adhesion molecule 1 (PECAM1, CD31). Von Willebrand Factor staining demonstrated discrete, granular, perinuclear localisation (Figure [figure omitted; refer to PDF] B), whilst CD31 was expressed at the region of cell-to-cell contacts (Figure [figure omitted; refer to PDF] C). HGMEC retained functional characteristics of the microvasculature, expressing E-selectin and P-selectin (CD62E/P) in response to tumor necrosis factor (TNF) stimulation (Figure [figure omitted; refer to PDF] D), whereas unstimulated cells did not (Figure [figure omitted; refer to PDF] E).
Figure 1
Characterisation of cultured human glomerular microvascular endothelial cells (HGMEC)
Characterisation of cultured human glomerular microvascular endothelial cells (HGMEC). A) Phase contrast micrograph of passage 3 purified HGMEC (magnification 200x), B and C) Immunofluorescence images of HGMEC probed for von Willebrand factor and PECAM1, respectively. D) and E) E selectin: HGMEC in panel D) were incubated for 12 hours with TNF alpha prior to fixation. No staining with E selectin was observed in unstimulated cells (E) . Texas red conjugated secondary antibodies were used for detection and nuclei were counter stained with Hoechst dye (blue). Original magnification in B-E was 630x.
[figure omitted; refer to PDF]
Transmission electron microscopy showed the presence of rod shaped microtubulated Weibel-Palade bodies (Figure [figure omitted; refer to PDF] A and B) which unambiguously identify the cells as endothelial [14]. Scanning electron microscopy demonstrated numerous fenestrae with a diameter of approx. 100 nm (Figure [figure omitted; refer to PDF] C). The presence of fenestrae as a hallmark of glomerular endothelial reflects the well-differentiated status of these cells [15].
Figure 2
Electron microscopy (EM) of cultured human glomerular microvascular endothelial cells (HGMEC)
Electron microscopy (EM) of cultured human glomerular microvascular endothelial cells (HGMEC). A) HGMEC were cultured on nitrocellulose membranes and processed for EM. Transmission EM showing general cell structures such as lysosome (L), mitochondria (M), and endoplasmic reticulum (ER). Also the endothelial characteristic Weibel Palade bodies can be seen (circle). B) Magnification of a Weibel Palade body from panel A) , showing rod shaped microtubules. C) Scanning EM of a HGMEC cell showing numerous fenestrae.
[figure omitted; refer to PDF]
HGMEC SAGE library
The final HGMEC SAGE library which was constructed using the short SAGE protocol as it is superior to the long SAGE protocol in identifying differential expression of tags [16] contained 68,987 tags with 18,385 unique tags after electronic removal of contaminating linker sequences (Additional file 1: Table S1). It has been approved by the Gene Expression Omnibus (GEO) data depository (http://www.ncbi.nlm.nih.gov/geo ) and assigned an accession number [GEO:GSM16892]. Key features of this library are shown in Table 1.
Additional file 1: Table S1
Complete HGMEC SAGE library after exclusion of linker sequences.
Click here for file
Table 1
Key features of the HGMEC SAGE library
Frequency | Genes | % of genes | Tags | % of tags | # of reliable unique tags | # of unique tags with no match |
> 10 | 1,038 | 5.6 | 39,078 | 56.6 | 908 | 3 |
5-9 | 1,163 | 6.3 | 7,541 | 10.9 | 938 | 14 |
2-4 | 4,019 | 21.9 | 10,203 | 14.9 | 2,465 | 170 |
1 | 12,165 | 66.2 | 12,165 | 17.6 | 3,239 | 1,608 |
Total | 18,385 | 68,987 | 7,550 | 1,795 |
Distribution of tags and genes (unique tags) based on SageGenie data.
Reliable tags: All tags with a ranking according to SAGE Genie [13] greater than 80% and not from an undefined 3' end. Tags with no match: All tags with no matching tags in the SAGE Genie database.
Verification of endothelial origin of HGMEC SAGE library
The library was confirmed to be of endothelial origin with a classification approach as explained in detail in the Methods section. In short, we used the sum of the relative expression of 150 tags (Additional file 2: Table S2) as a test statistic: a value larger than the threshold 0.022 indicates an endothelial origin. In other words, if the sum of the total copy numbers of these tags account for 2.2% or more, that library qualifies as endothelial. With a sum of 0.070 (7%) for these 150 tags our HGMEC SAGE library is clearly classified to be of endothelial origin (Figure [figure omitted; refer to PDF] ). Notably, two of the analyzed 18 endothelial cell SAGE libraries, "Vascular_endothelium_normal_breast_associated_P1H12 + _AP_1" [GEO: GSM384017] and "Normal corneal endothelium" [GEO: GSM1652], scored below the threshold of 0.022. Consequently, although this might be the reflection of a significant endothelial heterogeneity, only the remaining 16 endothelial cell SAGE libraries were merged to build a non-glomerular endothelial reference SAGE library for further analyses.
Additional file 2: Table S2
List of 150 tags used for endothelial classification as described in Figure [figure omitted; refer to PDF] .
Click here for file
Figure 3
Classification of glomerular microvascular endothelial cell (HGMEC) library as endothelial
Classification of glomerular microvascular endothelial cell (HGMEC) library as endothelial. A) Cross-validation using 63 non-endothelial and 18 endothelial SAGE-libraries not including HGMEC SAGE library. The minimum number of false classifications (false positive: a non-endothelial library classified as endothelial and false negative: an endothelial library classified as non-endothelial) was observed for n = 100 or 150 tags. B) Histogram showing the sum of relative expression for each of the endothelial and non-endothelial SAGE libraries as used for cross-validation in panel A) . The sum of relative tag counts of 150 tags discriminates between endothelial and non-endothelial SAGE libraries. If the sum is larger than the threshold 0.022, the library is characterised as endothelial. This threshold is clearly exceeded by the HGMEC SAGE library (0.07).
[figure omitted; refer to PDF]
Overlap analysis and mapping
After verification of the endothelial origin of this library, we took advantage of the existing public data (SAGE Genie) to reduce the high number of tags to a small group of relevant and differentially expressed tags in HGMEC. The algorithm we used as the research strategy is depicted in Figure [figure omitted; refer to PDF] . First, we determined overlapping transcripts from both the HGMEC SAGE library and the ex vivo glomerular library containing 44,334 tags [17]. This showed that 823 transcripts were shared by the cultured HGMEC and the non-cultured glomeruli that contain EC. This group represented transcripts in our HGMEC SAGE library with the potential of in vivo expression. Out of these 823 transcripts (Additional file 3: Table S3) 268 were differentially overexpressed in HGMEC using Chi-square test with p < 0.01 in comparison to the non-glomerular endothelial reference SAGE library (822,008 tags) and with the restriction that the observed count in HGMEC is higher than statistically expected (see Additional file 4: Table S4 for the complete list and Table 2 for the 50 most abundant tags as well as Additional file 5: Figure S1 for expression pattern by means of a volcano plot). To test whether our statistical analysis settings were adequate we applied multiple test correction to all p-values of the above described 823 transcripts by means of "false discovery rate (FDR)". This p-value cut-off only included tags with a false discovery rate of < 0.05 (Additional file 4: Table S4) and was thus expected to result in less than 5% false positives. Surprisingly, this procedure led to the detection of five additional overexpressed transcripts and therefore was less stringent than our previous p-value cut-off of 0.01 with no correction (Additional file 3: Table S3, the additional five transcripts are labelled). Adding these transcripts to the set of overexpressed transcripts did not have an influence on our data or their interpretation. Nevertheless, we added the FDR corrected p-values to Table 2, Additional file 3: Table S3 and Additional file 4: Table S4.
Figure 4
Short explanation of research strategy: Definition of HGMEC transcriptome by generation of SAGE library and identification of HGMEC predominant transcripts based on 4 criteria
Short explanation of research strategy: definition of HGMEC transcriptome by generation of SAGE library and identification of HGMEC predominant transcripts based on 4 criteria. HGMEC: human glomerular microvascular endothelial cell.
[figure omitted; refer to PDF]
Additional file 3: Table S3
Complete list of 823 tags common to SAGE libraries from HGMEC and ex vivo glomeruli. FDR: multiple test correction by false discovery rate.
Click here for file
Additional file 4: Table S4
Complete list of 268 tags which are common to SAGE libraries from HGMEC and ex vivo glomeruli and overexpressed in HGMEC compared to the 16 non-glomerular endothelial cell SAGE libraries including information on cytogenetic location of each tag. FDR: multiple test correction by false discovery rate.
Click here for file
Table 2
Expression of the 50 most abundant from 268 tags which were common to HGMEC and ex vivo glomerular SAGE libraries and overexpressed in HGMEC in comparison to the cumulative endothelial cell library
UniGene | P-value | FDR corrected p-value | Endo | HGMEC | Expected HGMEC | Description | Confirmed by RT-PCR |
hs.425125 | 0.00E + 000 | 0.00E + 000 | 145 | 551 | 88.38 | Ribosomal protein L29 (Hs00988959_gH) | + |
hs.514581 | 0.00E + 000 | 0.00E + 000 | 103 | 482 | 74.29 | Actin, gamma 1 | |
hs.586423 | 0.00E + 000 | 0.00E + 000 | 29 | 434 | 58.80 | Eukaryotic translation elongation factor 1 alpha 1 (Hs00265885_g1) | + |
hs.182825 | 0.00E + 000 | 0.00E + 000 | 83 | 413 | 62.99 | Ribosomal protein L35 | |
hs.632703 | 0.00E + 000 | 0.00E + 000 | 8 | 407 | 52.70 | Ribosomal protein L41 | |
hs.445351 | 0.00E + 000 | 0.00E + 000 | 33 | 394 | 54.22 | Lectin, galactoside-binding, soluble, 1 (galectin 1) | |
hs.522584 | 0.00E + 000 | 0.00E + 000 | 18 | 380 | 50.54 | Thymosin beta 4, X-linked (Hs03406519_gH) | + |
hs.374596 | 0.00E + 000 | 0.00E + 000 | 53 | 353 | 51.56 | Tumor protein, translationally-controlled 1 | |
hs.91481 | 0.00E + 000 | 0.00E + 000 | 24 | 319 | 43.56 | EGF-like-domain, multiple 7 (Hs00211952_m1) | + |
hs.523185 | 0.00E + 000 | 0.00E + 000 | 62 | 286 | 44.19 | Ribosomal protein L13a | |
hs.524910 | 0.00E + 000 | 0.00E + 000 | 32 | 252 | 36.06 | Ferritin, heavy polypeptide 1 | |
hs.546286 | 0.00E + 000 | 0.00E + 000 | 23 | 237 | 33.02 | Ribosomal protein S3 (Hs02385124_g1) | + |
hs.265174 | 1.96E-305 | 1.24E-303 | 9 | 215 | 28.45 | Ribosomal protein L32 | |
hs.494691 | 1.20E-288 | 7.05E-287 | 199 | 355 | 70.35 | Profilin 1 (Hs00277097_m1) | + |
hs.446574 | 4.37E-285 | 2.40E-283 | 13 | 206 | 27.81 | Thymosin beta 10 (Hs00363670_m1) | + |
hs.400295 | 4.05E-268 | 2.08E-266 | 0 | 179 | 22.73 | Ribosomal protein L30 | |
hs.388664 | 8.04E-253 | 3.89E-251 | 49 | 220 | 34.16 | Ribosomal protein L11 | |
hs.546269 | 4.36E-246 | 1.99E-244 | 130 | 277 | 51.68 | Ribosomal protein L10a | |
hs.433427 | 1.91E-226 | 8.27E-225 | 45 | 198 | 30.86 | Ribosomal protein S17 | |
hs.515070 | 1.04E-224 | 4.28E-223 | 28 | 181 | 26.54 | Eukaryotic translation elongation factor 2 | |
hs.144835 | 4.47E-213 | 1.75E-211 | 66 | 206 | 34.54 | Eukaryotic translation elongation factor 1 gamma | |
hs.523463 | 9.00E-212 | 3.37E-210 | 50 | 192 | 30.73 | Ribosomal protein L27a (Hs00741143_s1) | + |
hs.275243 | 9.12E-204 | 3.26E-202 | 0 | 136 | 17.27 | S100 calcium binding protein A6 (Hs01002197_g1) | + |
hs.654404 | 1.62E-196 | 5.56E-195 | 182 | 269 | 57.27 | Major histocompatibility complex, class I, C | |
hs.437594 | 1.55E-187 | 5.10E-186 | 79 | 197 | 35.05 | Ribosomal protein, large, P2 | |
hs.397609 | 1.12E-182 | 3.55E-181 | 12 | 136 | 18.79 | Ribosomal protein S16 | |
hs.111779 | 1.18E-178 | 3.60E-177 | 32 | 153 | 23.49 | Secreted protein, acidic, cysteine-rich (osteonectin) (Hs00234160_m1) | + |
hs.438429 | 1.19E-170 | 3.50E-169 | 177 | 244 | 53.46 | Ribosomal protein S19 | |
hs.605502 | 4.11E-150 | 1.17E-148 | 12 | 114 | 16.0 | Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) (Hs00607129_gH) | + |
hs.546288 | 8.08E-149 | 2.22E-147 | 144 | 207 | 44.57 | Ribosomal protein S9 | |
hs.632717 | 1.24E-145 | 3.29E-144 | 88 | 171 | 32.89 | Myosin, light chain 6, alkali, smooth muscle and non-muscle (Hs02597812_g1) | + |
hs.627414 | 3.86E-142 | 9.93E-141 | 102 | 177 | 35.43 | Ribosomal protein S18 | |
hs.381219 | 1.80E-138 | 4.49E-137 | 10 | 104 | 14.48 | Ribosomal protein L15 | |
hs.410817 | 7.03E-122 | 1.70E-120 | 200 | 211 | 52.19 | Ribosomal protein L13 | |
hs.511605 | 3.74E-121 | 8.79E-120 | 21 | 103 | 15.75 | Annexin A2 (Hs00743063_s1) | + |
hs.17441 | 6.13E-121 | 1.40E-119 | 28 | 109 | 17.40 | Collagen, type IV, alpha 1 (Hs00266237_m1) | + |
hs.520898 | 9.10E-117 | 2.02E-115 | 6 | 85 | 11.56 | Cathepsin B (Hs00947433_m1) | + |
hs.356572 | 2,11E-115 | 2,11E-115 | 63 | 132 | 24,76 | Ribosomal protein S3a | |
hs.170622 | 1.25E-112 | 2.64E-111 | 378 | 275 | 82.92 | Cofilin 1 (non-muscle) (Hs02621564_g1) | + |
hs.278573 | 2.63E-112 | 5.41E-111 | 6 | 82 | 11.17 | CD59 molecule, complement regulatory protein (Hs00174141_m1) | + |
hs.433701 | 1.37E-109 | 2.75E-108 | 126 | 163 | 36.70 | Ribosomal protein L37a | |
hs.8372 | 2.40E-104 | 4.70E-103 | 23 | 93 | 14.73 | Ubiquinol-cytochrome c reductase, 6.4 kDa subunit | |
hs.527193 | 9.87E-103 | 1.89E-101 | 22 | 91 | 14.35 | Ribosomal protein S23 | |
hs.387208 | 8.69E-096 | 1.63E-094 | 13 | 78 | 11.56 | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed | |
hs.437191 | 1.83E-094 | 3.35E-093 | 23 | 86 | 13.84 | Polymerase I and transcript release factor (Hs00396859_m1) | + |
hs.591346 | 6.61E-094 | 1.18E-092 | 63 | 114 | 22.48 | Connective tissue growth factor (Hs01026926_g1) | + |
hs.644628 | 1.40E-091 | 2.45E-090 | 167 | 166 | 42.29 | Ribosomal protein L4 | |
hs.77961 | 2.67E-089 | 4.58E-088 | 44 | 98 | 18.03 | Major histocompatibility complex, class I, B | |
hs.594444 | 2.09E-088 | 3.51E-087 | 8 | 68 | 9.65 | Lamin A/C (Hs00153462_m1) | + |
hs.446628 | 4.24E-087 | 6.98E-086 | 81 | 119 | 25.40 | Ribosomal protein S4, X-linked |
UniGene numbers represent the UniGene groups to which the tags are assigned. P-value refers to expression comparison between HGMEC and Endo. FDR: multiple test correction using false discovery rate. Endo: Detected total copy number in the non-glomerular endothelial reference SAGE library. HGMEC: Detected copy number in HGMEC. Expected HGMEC: number of this particular tag statistically expected in HGMEC SAGE library by means of Chi-square statistics; Confirmed by RT-PCR: for these randomly chosen tags (n = 20) qRT-PCR was performed to confirm their expression in HGMEC. +: confirmation by qRT-PCR was successful (thus expression of all 20 transcripts confirmed by a TaqMan® Assay; each assay ID is shown in brackets).
Additional file 5: Figure S1
Volcano plot showing p-values against log fold change for the 823 transcripts from Additional file 3: Table S3. Each red dot symbolizes one transcript which is common to HGMEC and ex vivo glomeruli and is enriched in HGMEC when compared to non-glomerular endothelial cells (268 transcripts from Additional file 4: Table S4). The plot shows a typical appearance except that because of the high p-values some of the sample points are accumulated on both over- (positive values on the x-axis) and underrepresentation (negative values on the x-axis) sides. Note the logarithmic scaling of the y-axis.
Click here for file
The expression of 20 randomly chosen tags from Table 2 was confirmed by quantitative RT-PCR (qRT-PCR). The cytogenetic locations of the 268 transcripts are noted in Additional file 6: Figure S2. According to this analysis chromosomes 1, 6, 11, 17 and 19 are carrying 43% of these genes.
Additional file 6: Figure S2
Chromosome distribution of 268 HGMEC enriched genes as listed in Additional file 4: Table S4.
Click here for file
Gene Ontology (GO) analysis
We identified the GO terms present in the 268 overexpressed genes by mapping them to the GO Biological Process and determining whether they occur more often in a category than expected. We defined a category to be redundant if its child term contained the same genes. Among the 60 detected categories 12 redundant child terms were deleted. The remaining most significant categories resulted in five connected components in the Gene Ontology graph that are listed in Table 3. The known interplay between different ubiquitination processes and apoptosis in different biological systems such as TNF receptor signaling [18] is reflected in HGMEC by the overexpression of many GO terms from these biological processes. Ubiquinol to cytochrome c ("Translation and energy metabolism" cluster) and nuclear migration ("Nuclear migration" cluster) are not displayed in Table 3 despite their significant overexpression due to the small numbers of molecules in the GO-terms mitochondrial electron transport. Nonetheless, in the case of "nuclear migration" (thought to be a common process of neuroepithelia in development and enabling the migration of nucleus between apical and basal surfaces) both of the molecules in this cluster were overexpressed in HGMEC and also in the regulatory microtubule associated molecule Tpx2 [19]. This is not a high abundance molecule and yet it was clearly detected in our HGMEC SAGE library (5.8 copies/200,000). Our GO analysis demonstrates that HGMEC have high expression of ribosomal proteins (23 out of 50 most abundant tags, Table 2). Also, molecules involved in interspecies interactions and cytoskeleton organization are enriched in HGMEC. One of two other molecules of interest in the glomerular endothelium, the von Willebrand cleaving protease ADAMTS13 [GenBank: NM_139025], tag CAGGCTGAAA, was not detected in HGMEC or in any other endothelial SAGE library except in the endothelium of the normal colon (12 copies/200,000). On the other hand caveolin-1 involved in endo- and transcytosis [20] (CAV1, [GenBank:NM_001753], tag TCCTGTAAAG, has a significant expression level in HGMEC (197 copies/200,000). Interestingly, the pathway analysis in HGMEC and dermal human microvascular EC (Vascular_normal_CS_control) SAGE libraries revealed novel differences regarding caveolae between these two microvascular endothelial cell types. In caveolae pathway caveolin-1, -2 and -3 were all present in HGMEC and absent in dermal microvascular EC. A complete list of molecules from this pathway present in HGMEC and absent in dermal microvascular EC is shown in Additional file 7: Table S5.
Table 3
Excerpt of gene ontology (GO) cluster classification
GO ID | P-value | HGMEC count | Total count | GO Term |
Cluster 1 (Translation and energy metabolism) | ||||
GO:0031145 | 2.64E-004 | 7 | 59 | Anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO:0043161 | 2.24E-004 | 8 | 76 | Proteasomal ubiquitin-dependent protein catabolic process |
GO:0006511 | 3.08E-003 | 10 | 165 | Ubiquitin-dependent protein catabolic process |
GO:0044265 | 8.83E-004 | 15 | 274 | Cellular macromolecule catabolic process |
GO:0044260 | 2.60E-009 | 81 | 2044 | Cellular macromolecule metabolic process |
GO:0043170 | 1.84E-003 | 112 | 4217 | Macromolecule metabolic process |
GO:0006414 | 9.54E-049 | 41 | 78 | Translational elongation |
GO:0006412 | 2.67E-027 | 48 | 326 | Translation |
GO:0043284 | 3.35E-004 | 61 | 1871 | Biopolymer biosynthetic process |
GO:0009059 | 1.31E-004 | 72 | 2251 | Macromolecule biosynthetic process |
GO:0044249 | 2.86E-004 | 68 | 2142 | Cellular biosynthetic process |
GO:0009058 | 1.95E-003 | 76 | 2627 | Biosynthetic process |
GO:0044237 | 5.08E-003 | 128 | 5073 | Cellular metabolic process |
GO:0010467 | 1.39E-004 | 74 | 2337 | Gene expression |
GO:0009987 | 2.55E-004 | 184 | 7730 | Cellular process |
GO:0006120 | 3.76E-003 | 4 | 30 | Mitochondrial electron transport, NADH to ubiquinone |
GO:0042775 | 1.27E-004 | 6 | 37 | Organelle ATP synthesis coupled electron transport |
GO:0006119 | 1.90E-004 | 7 | 56 | Oxidative phosphorylation |
GO:0006096 | 9.71E-003 | 4 | 39 | Glycolysis |
GO:0006091 | 5.24E-005 | 14 | 187 | Generation of precursor metabolites and energy |
Cluster 2 (Ubiquitination) | ||||
GO:0051437 | 4.62E-005 | 8 | 61 | Positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle |
GO:0043085 | 2.93E-003 | 13 | 249 | Positive regulation of catalytic activity |
GO:0051436 | 2.37E-004 | 7 | 58 | Negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle |
GO:0043086 | 8.56E-003 | 8 | 134 | Negative regulation of catalytic activity |
Cluster 3 (Interspecies interaction) | ||||
GO:0044419 | 1.18E-004 | 13 | 177 | Interspecies interaction between organisms |
GO:0051704 | 5.88E-004 | 17 | 321 | Multi-organism process |
Cluster 4 (Apoptosis) | ||||
GO:0006916 | 1.15E-003 | 9 | 120 | Anti-apoptosis |
GO:0043066 | 4.15E-003 | 10 | 172 | Negative regulation of apoptosis |
GO:0051093 | 6.73E-003 | 12 | 244 | Negative regulation of developmental process |
GO:0042981 | 4.69E-003 | 17 | 390 | Regulation of apoptosis |
GO:0006915 | 6.48E-003 | 22 | 575 | Apoptosis |
GO:0050793 | 7.01E-003 | 22 | 579 | Regulation of developmental process |
Cluster 5 (Cytoskeleton organization) | ||||
GO:0030036 | 2.25E-003 | 10 | 158 | Actin cytoskeleton organization and biogenesis |
GO:0030029 | 1.32E-003 | 11 | 173 | Actin filament-based process |
GO:0007010 | 6.17E-003 | 16 | 368 | Cytoskeleton organization and biogenesis |
Into this GO analysis only 268 tags were included which were expressed in ex vivo glomeruli as well predominant to HGMEC when compared to other 16 types of EC. Total count: number of molecules present in the cluster; HGMEC count: how many of the total number of molecules in a cluster are present in HGMEC; p-value: comparison between the total number of members in a cluster and the count of those which are expressed in HGMEC as a sign of enrichment.
Additional file 7: Table S5
Lists of caveolae pathway molecules present in HGMEC and absent in dermal microvascular endothelial cells. Connectivity: high degree of connectivity represents proteins which are more likely to be essential for survival.
Click here for file
Glomerular and non-glomerular endothelial expression of neurogranin
To identify transcripts with the highest potential to be novel and HGMEC pre-dominant we applied the final group of transcripts of interest containing 268 tags (common to ex vivo glomeruli and differentially overexpressed in HGMEC when compared with non-glomerular endothelial cells) to a set of additional criteria: a) completely absent in all other nephron regions ex vivo [17] and b) more highly expressed than statistically expected in HGMEC. Ultimately, one transcript fulfilled all these criteria, namely NRGN. Its expression in HGMEC equalled to 192% of the statistically expected expression and it was enriched in HGMEC when compared to ex vivo glomerulus or to the fusion endothelial reference library with 52 versus 25 copies or 52 versus 21 copies per 200,000 tags, respectively. It was on position 174 when sorted from highest to the lowest expression level in the group of 268 tags (Additional file 4: Table S4). The corresponding tag for NRGN is TGACTGTGCT. Based on the SageGenie algorithm from Boon et al. [13] this tag has a high ranking of 95% and is classified as a reliable 3' end of NRGN RefSeq transcripts [NM_001126181] and [NM_006176], which strongly supported the validity of the tag. Neurogranin transcript expression in GEnC under non-permissive conditions (5 days at 37°C) was shown by quantitative RT-PCR and the 116 bp long product was cloned, sequenced and matched the NRGN RefSeq transcript [NM_001126181], 237 bp, 100% (Figure [figure omitted; refer to PDF] ). To confirm the expression of NRGN in the glomerular EC in vivo , frozen sections of human kidney were co-immunostained for NRGN (Figure [figure omitted; refer to PDF] C) and the EC marker vWF (Figure [figure omitted; refer to PDF] D). As shown in Figure [figure omitted; refer to PDF] E, both proteins show a significant co-localization confirming the transcriptional data that NRGN is expressed in the kidney's glomerular EC. No reactivity was observed with secondary antibodies alone (Figure [figure omitted; refer to PDF] A and B). The endothelial expression of NRGN is further corroborated by the in silico analysis using each of the 18 publicly available endothelial libraries considered for the reference endothelial library. We found that 14 of them expressed the NRGN tag to some extent (Table 4), with a mean number of NRGN tags per 200,000 of 27.7 (standard deviation = 20.9).
Figure 5
Amplification of a 116 bp fragment of the human neurogranin cDNA from cDNA isolated from immortalized human glomerular endothelial cell line GEnC
Amplification of a 116 bp fragment of the human neurogranin cDNA from cDNA isolated from immortalized human glomerular endothelial cell line GEnC. Agarose gel (1.5%) electrophoresis of 10 μL qPCR product using a template of cDNA generated by reverse transcription of total RNA isolated from GEnC (lane 1) or ddH2 O as a negative control (lane 2).
[figure omitted; refer to PDF]
Figure 6
Immunofluorescence images of sections of human kidney showing glomerular expression of NRGN
Immunofluorescence images of sections of human kidney showing glomerular expression of NRGN. Cryosections of human kidney were stained for neurogranin (NRGN) with anti-NRGN antibodies (C) , von-Willebrand factor (vWF) with anti-vWF antibodies (D) and second antibodies alone (A and B) . Signals of NRGN (red) and vWF (green) were merged in (E) .
[figure omitted; refer to PDF]
Table 4
List of all 18 non-glomerular endothelial SAGE libraries analyzed. 16 were merged to create the non-glomerular endothelial reference SAGE library
SAGE library | Number of tags | Gene expression omnibus (GEO) dataset number | Number of NRGN tag per 200,000 |
Vascular_endothelium_breast_carcinoma_associated_P1H12 + _AP_DCIS6 | 65223 | GSM384015 | 9 |
Vascular_endothelium_hemangioma_B_146 | 75680 | GSM384016 | 8 |
Vascular_normal_CS_control | 51562 | GSM384019 | 0 |
Vascular_normal_CS_VEGF+ | 57316 | GSM384020 | 7 |
Endothelium of normal colon | 95327 | provided by Dr. K. Kinzler | 17 |
Endothelium of colon tumor | 95543 | provided by Dr. K. Kinzler | 2 |
Microvascular endothelial cells cultured on advanced glycatedfibronectin and exposed to sustained high shear stress | 24773 | GSM45608 | 8 |
Microvascular endothelial cells cultured on fibronectin and exposed to sustained high shear stress | 30615 | GSM32266 | 19 |
Microvascular endothelial cells cultured on fibronectin and exposed to sustained low shear stress | 31141 | GSM41248 | 19 |
Vascular_endothelium_normal_liver_associated_AP_NLEC1 | 77759 | GSM384018 | 0 |
Human Aortic Endothelial Cell Exposure to 0 h Short-Term Chronic Hypoxia (Control) | 38446 | GSM62240 | 57 |
Human Aortic Endothelial Cell Exposure to 8 h Short-Term Chronic Hypoxia | 40629 | GSM62241 | 39 |
Human Aortic Endothelial Cell Exposure to 24 h Short-Term Chronic Hypoxia | 42371 | GSM62242 | 52 |
Human Pulmonary Artery Endothelial Cell Exposure to 0 h Short-Term Chronic Hypoxia (Control) | 25706 | GSM62243 | 46 |
Human Pulmonary Artery Endothelial Cell Exposure to 8 h Short-Term Chronic Hypoxia | 27666 | GSM62244 | 58 |
Human Pulmonary Artery Endothelial Cell Exposure to 24 h Short-Term Chronic Hypoxia | 42251 | GSM62245 | 47 |
Normal corneal endothelium | 9537 | GSM1652 | 0 |
Vascular_endothelium_normal breast_associated_P1H12 + _AP_1 | 34373 | GSM384017 | 0 |
The last two libraries in italic were not included in the non-glomerular endothelial reference SAGE library based on their failure to be clearly classified of endothelial origin according to our verification analysis as explained in Methods.
NRGN: neurogranin.
Two of the four libraries which did not contain the NRGN tag, were the ones which were below the "endothelial" threshold (Figure [figure omitted; refer to PDF] B) and thus not included into the fusion endothelial reference library. The other two were "Vascular normal_CS_control" from dermal microvascular EC and "Vascular_endothelium_normal_liver_associated_AP_NLEC1". According to these data treatment of dermal microvascular EC with vascular growth factor (VEGF) known as a differentiation factor for EC [21] led to a detectable expression of NRGN, as shown in the "Vascular normal_CS_VEGF+" library (Table 4).
Discussion
Human glomerular endothelium is composed of highly specialized cells. Their molecular features leading to the unique phenotype remain largely unknown. In this study we define the transcriptome of HGMEC using SAGE [12]. Serial analysis of gene expression gives exceptionally unbiased transcriptional data because it is based on extraction of unique sequence tags for each distinct transcript, known or unknown, differentially expressed or not, from a population of transcripts. The frequency with which a given tag is present in a SAGE library reflects the abundance of its transcript resulting in quantification of obtained data. Thus, it does not involve error prone statistics resulting from comparison to laboratory controls and thus its data are readily comparable among different laboratories. Moreover, it obtains a broader snapshot of gene expression when compared to the commercial arrays [22]. These clearly distinguish SAGE from other methods used for similar purposes. Also, in endothelial cell research SAGE has proven to be both reliable and successful [23-25]. It has to be noted that more recent and advanced high throughput sequencing methods such as deep RNA sequencing were considered for this study. This particular method displays similarities to SAGE regarding the linearity over a wide range of transcripts from low to high abundance as well as some technical advantages. It can work with significantly less starting material at a higher speed, with less work-load and cost for large sets of raw data from a single experiment to detect novel splice variants or alternative transcription sites [26-27]. Yet, SAGE was the method of choice when designing the study due to the combination of its validity and the availability of unprecedented, large, well-maintained datasets and quality-controlled databases from SAGE libraries (e.g. Cancer Genome Anatomy Project including many endothelial cell types and glomeruli).
The main challenges of transcriptional studies remain a) the sequencing errors, which was reported to account for approximately 10% of tags in SAGE [28], b) the validation of detected transcripts, c) managing the vast number of transcripts and d) not "overseeing" novel transcripts of interest which are present, but not easily "visible" in the transcript library. In this study, these issues were addressed by incorporation of advanced bioinformatics and conventional methods such as real-time PCR and immunohistochemistry. Our bioinformatics strategy allowed verification of endothelial origin of the HGMEC as well as 16 out of the 18 SAGE libraries which were publicly available at the time (Table 4). The failure of two established endothelial SAGE libraries to qualify as endothelial using our methodology deserves to be mentioned. Although many possible explanations can be given for this phenomenon, we suggest that this is based on the significant differences between endothelia accounting for endothelial diversity. Nevertheless, we chose not to incorporate the transcript tags from these libraries into the non-glomerular endothelial reference library, although according to our calculations this would not change any statement or conclusion of this study. Furthermore, exclusion of singletons and comparison of HGMEC SAGE library first with ex vivo glomerular then with 16 endothelial SAGE libraries were fundamental. Only HGMEC-enriched tags with a significant overlap between HGMEC and ex vivo glomeruli under the simultaneous exclusion of common transcripts with non-glomerular endothelial cells were used for analyses, thus the probability of chasing tags based on sequencing errors was further minimized. Thus, expression of all the 20 randomly chosen transcripts in the resulting list of overexpressed HGMEC transcripts could be verified by qRT-PCR. Finally, robustness of our strategy was additionally validated by the demonstration of NRGN, a low-abundant molecule previously thought to be brain specific, in human glomerular endothelium in vitro and in vivo for the first time. Interestingly, although this transcript had never been known in kidney or any endothelial cell, our analysis showed that it was present in some previously generated endothelial SAGE libraries but was never recognized due to a lack of a strategy such as the one described in this study. The results from this stepwise procedure provide valuable large lists of transcripts expressed in human glomerular endothelium which have a high potential to be present in vivo and underline endothelial diversity.
Moreover, a genetic analysis of glomerular EC is especially intriguing: Not only because their uniqueness is evident in their morphology, behaviour in culture, and disease [2-37], but also because it is postulated that they have a distinct embryological origin and that the developing kidney generates its own endothelium [38]. Because the origin of distinct HGMEC features in vitro or in vivo is not fully understood, we defined the transcriptome of human glomerular endothelium by means of SAGE using HGMEC in culture which carried typical characteristics of differentiated glomerular endothelium including fenestrations and particularly focused on transcripts which are common to HGMEC and non-cultured ex vivo glomeruli. Only those transcripts were exposed to further analysis regarding their presence or absence in a fusion endothelial reference library. Thus, the vast numbers of transcripts were gradually reduced to manageable numbers and to relevant lists which are presented here. Next, these lists were explored in increasing depth. At first glance the remarkable abundance of ribosomal proteins in the HGMEC SAGE library was evident by the presence of 23 different ribosomal proteins among the most abundant 50 tags. We argue that this is not a mere consequence of cell culture and is a pattern found in other SAGE libraries from non-cultured cells, e.g. human monocytes (27 ribosomal proteins in the most abundant 50 transcripts) [39]. High translational activity possessed by HGMEC was reflected by the overexpression of "translation and energy metabolism" GO cluster. According to the GO analysis another cluster which was more abundant than statistically expected in HGMEC was "ubiquitination". Ubiquitination is a posttranslational modification of proteins. Monoubiquitination is involved in various processes e.g. in endocytosis or transcriptional regulation. In contrast, polyubiquitination of a protein results in recognition and degradation of this protein [40]. In this context, it is noteworthy that internalization and transport of proteins, particularly albumin, is of special interest in physiology as well as pathology of glomerular endothelium, both of which involve caveolins. A major caveolin is caveolin-1 (CAV1) which is significantly related to albumin excretion [41]. Ubiquitination seems to be responsible also for the turnover for CAV1. Hence, the presence of CAV1 in HGMEC SAGE library and enrichment of ubiquitination GO terms in addition to high concentration of ribosomal proteins substantiate the previously suggested characteristics of glomerular endothelium. Novel differences between different microvascular EC appeared by comparing caveolae pathway: in contrast to HGMEC the dermal microvascular EC (Vascular_normal_CS_control) did not express any of the caveolin 1-3 in addition to some other qualitative differences (Additional file 7: Table S5). Our results regarding the absence of ADAMTS13 in HGMEC are conflicting. The presence of this von Willebrand cleaving protease had been demonstrated in immortalized glomerular as well as in dermal microvascular EC before [42]. In most of the previously established endothelial SAGE libraries including dermal microvascular EC (Vascular_normal_CS_control and Vascular_normal_CS_VEGF) this molecule was not detected. Neither a complete kidney (SAGE_Kidney_normal_B_1, GSM383901, data not shown) nor the liver endothelial cell SAGE library (Vascular_endothelium_normal_liver_associated_AP_NLEC1, GSM384018, Table 4) expressed any ADAMTS13 tags, although liver and kidney cells were used as positive controls in the study by Tati et al. Only the SAGE library from endothelium of normal colon expressed ADAMTS13. Probably, this is due to the low abundance of this molecule as it was demonstrated by its appearance only at high cycle numbers of RT-PCR experiments especially in human glomerular and microvascular EC [42]. It can be argued that in spite of remarkable tag numbers the sizes of the SAGE libraries were too small to detect this transcript.
Finally, when obtained transcript lists were further filtered using additional criteria (expression in HGMEC higher then statistically expected, overexpressed in HGMEC when compared to the non-glomerular endothelial reference SAGE library, never before shown in kidney or any endothelial cell type, higher expression in HGMEC than in other endothelial cell types) only one low abundance transcript, namely NRGN, stood out. It is reasonable to assume that a larger size of HGMEC SAGE library would probably lead to the detection of a higher number of NRGN tags and more transcripts fulfilling same criteria. Subsequently, we first confirmed the presence of NRGN transcript in HGMEC by sequencing and then the in vivo expression of NRGN protein in human glomerular endothelium by immunohistochemistry. Thus far, NRGN was believed to be brain specific and abundant in forebrain neurons whose interactions with calmodulin are suggested to play an important role in the regulation of synaptic responses and plasticity [43-44]. In brain, NRGN expression is dependent on thyroid hormones [45] and it is a direct target of thyroid hormone action [46-48]. There are numerous studies suggesting a link between thyroid and glomerular functions starting from embryogenesis [49] and involving chronic kidney disease as well as acute kidney injury [50], glomerular filtration rate [51] or resistant proteinuria [52]. Recent data in a rat model showed that proteinuria seen in hyperthyroidism is not due podocyte pathology and that hyper- as well as hypothyroidism lead to an increased capillary density when compared to control animals while hyperthyroidism resulted in an expansion of glomerular area [53]. Yet, molecules linking both organ systems have never been defined. We postulate that NRGN in glomerular endothelium represents a potential link between the kidney and the thyroid as this was described for brain and thyroid. Studies are underway to test the function of glomerular endothelial NRGN in the thyroid-kidney axis.
Conclusions
In this study we describe and analyze a HGMEC SAGE library as the first quantitative description of the human glomerular endothelial transcriptome. By using open-source SAGE data from uncultured glomeruli and from 16 other non-glomerular endothelial cell types which were merged to gain a reference endothelial library as well as by employing specific in-silico analyses an efficient research strategy was established. In this method we included an analysis to verify the declared origin of large transcript lists and strongly suggest this or similar analyses should be employed whenever using such transcript lists before including them in the studies, because 11% of the analyzed endothelial SAGE libraries failed to qualify as such. Also, integration of additional stringent filters into the bioinformatics to reduce the vast number of transcripts to manageable groups appeared to be indispensable. The described multi-step strategy which also involved GO and pathway analyses was capable of determining a list of genes potentially expressed in vivo , highlighting glomerular endothelial uniqueness as well as endothelial diversity and identifying the low abundant NRGN for the first time in glomerular endothelium and confirming its expression in vitro and in vivo. The demonstration of NRGN as a molecule potentially linking glomerulus to thyroid and the sufficiency of our transcriptomic data providing a novel insight in significant differences between the glomerular and other endothelia represent novel and exciting findings in glomerular endothelial research.
Methods
Culture of primary HGMEC
Human glomerular microvascular EC were isolated and cultured as previously described [54]. Briefly, human renal tissue was obtained, with informed consent, from macroscopically healthy pieces of nephrectomized kidneys. Written consent from patients was obtained before the surgery (Ethics Committee of the Medical University of Vienna protocol approval number EK 141/2002 047/05/2008 ensuring adherence to The Declaration of Helsinki). Isolated glomeruli from minced cortex were digested and plated on fibronectin coated cell culture dishes. After 7 days in cell culture medium including fetal calf serum (FCS), 50 μg/mL endothelial cell growth supplement, 30 U/mL heparin, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mM alanine-glutamine HGMEC constituted approx. 10% of glomerular outgrowths. HGMEC were isolated from this mixed culture using CD31 immuno-magnetic sorting as per manufacturer's instructions (Dynal, Hamburg, Germany). HGMEC were passaged 4 to 8 times.
Immortalized human glomerular endothelial cell line
Conditionally immortalized GEnC line was kindly provided by Dr. Satchell and Dr. Mathieson (University of Bristol, UK) and these cells were kept as instructed [9].
HGMEC characterisation
HGMEC were seeded onto fibronectin coated glass cover slips, and cultured until near confluence prior to fixation. For immunostaining of intracellular antigens cell monolayers were permeabilised by incubation in 1% Triton-X-100 for 20 min. Non-specific binding sites were blocked by incubating 1 h in blocking solution (5% (w/v) non-fat milk in phosphate-buffered saline (PBS). Primary antibody was incubated at 1 μg/mL for CD62P/E and CD31 and at 30 μg/mL for vWF for 1 hour. After probes were rinsed 3-times Texas red conjugated secondary antibody was incubated at 1:200 in antibody solution. To test the upregulation of CD62P/E cells were treated with human recombinant TNF alpha for 12 hours at 100U/mL.
Transmission electron microscopy of HGMEC
Human glomerular EC grown on microporous inserts were fixed with 1% glutaraldehyde, buffered with PBS, post fixed in 1% OsO4 buffered with Na-cacodylate (0.1 M), dehydrated in graded series of ethanol, and embedded in Polybed. Ultrathin sections were stained conventionally by uranyl acetate and lead citrate and were examined with a JOEL 100 C electron microscope at 100 KV.
Scanning electron microscopy of HGMEC
HGMEC were fixed with Karnowsky's fixative, post fixed in 1% OsO4 buffered with Na-cacodylate (0.1 M), dehydrated in graded series of methanol, and submitted to critical point drying using CO2 . Dried specimen were sputter coated with a 120 Å gold palladium layer and examined with a JOEL JSM 25-S scanning electron microscope.
Construction of the HGMEC SAGE library
SAGE libraries were constructed from cultured primary HGMEC according to the short SAGE protocol [12] as described at http://www.sagenet.org with modifications described previously [23-24].
Confirmation of the endothelial origin of the HGMEC SAGE library
To confirm the endothelial origin of HGMEC SAGE library we applied a novel classification strategy as a learning process to distinguish endothelial libraries from others. Positive examples were eighteen endothelial SAGE libraries (Table 4) not including HGMEC. Negative examples were 63 SAGE libraries from non-endothelial normal tissues obtained from SAGE Genie (Additional file 8: Table S6). Only tag counts ≥2 were used and all tags which occurred in at least one of the libraries with a count ≥2 were considered. These were included in a tag-wise Wilcoxon rank sum test with the null hypothesis that the median expression of each tag is equal in both classes, and the alternative hypothesis that the median expression is larger in the endothelial libraries compared to the other libraries. The strategy was to select n tags highly expressed in endothelial libraries. In a subsequent step, the sum of the relative copy number of these tags was defined as an indicator for endothelial origin. The threshold was defined as the cut-off value to minimize wrong classifications based on the histogram consisting of sum of copy numbers of n tags. As shown in Figure [figure omitted; refer to PDF] B the chosen threshold 0.022 resulted in only 2 wrong classifications. To determine the optimal number of tags (n ) to best distinguish endothelial from non-endothelial, we repeated the above described procedure using different numbers of n from 50 to 1000 tags (Figure [figure omitted; refer to PDF] A). The minimum number of false classifications was observed for n = 100 or 150 (Figure [figure omitted; refer to PDF] A). We chose 150 tags as depicted in Additional file 2: Table S2 for classifying the HGMEC SAGE library. Using these tags and the threshold of 0.022 the HGMEC SAGE library was clearly classified as endothelial (Figure [figure omitted; refer to PDF] B).
Additional file 8: Table S6
List of the 63 non-endothelial SAGE libraries which were used for the algorithm to verify the endothelial origin of a given SAGE library.
Click here for file
Construction of a non-glomerular endothelial reference SAGE library
To obtain an endothelial reference library, sixteen endothelial SAGE libraries (Table 4) were merged to form a cumulative endothelial SAGE library as a reference library consisting of 822,008 tags.
Analysis of differential expression of transcripts and tag-to-gene mapping
First, all tags with a copy number = 1 were eliminated from the HGMEC SAGE library. For determining the transcripts potentially present in vivo and specific for HGMEC we then combined the information present in the HGMEC SAGE library and in the ex vivo glomerular library by Chabardes-Garonne et al. [17]. We designated a transcript as being a potential HGMEC transcript if it occurred at least three times in the HGMEC SAGE library and in the ex vivo glomerular library. Each of these HGMEC transcripts was tested for overexpression compared with the cumulative non-glomerular endothelial reference SAGE library (Chi-Square-Test, p < 0.01).
Comparisons between libraries (HGMEC, glomerular, cumulative non-glomerular endothelial reference SAGE library) were performed in a Microsoft ACCESS database. Resulting tags (common or differentially expressed among libraries) or entire tag lists from libraries were automatically identified over the web by means of "IdenTAG". IdenTAG was written in PERL specifically for this study and implemented a web-client tailored for the SAGE Genie site ( http://cgap.nci.nih.gov/SAGE/AnatomicViewer ) [13] of the Cancer Genome Anatomy Project at the US National Cancer Institute.
Gene Ontology and pathway analysis
For GO analysis of the overexpressed transcripts the UniGene-IDs were mapped via SAGE Genie to the corresponding Gene Symbols. Overrepresentation of genes in a GO category was determined by the Fisher test (p < 0.01). Subsequently, we identified the main functional categories present in these overexpressed genes by mapping them to GO Biological Process and determining whether they occur more often in a category than expected. All statistical analyses including the false discovery rate correction (p < 0.05) and the annotation with GO Terms were performed using R (http://www.r-project.org ) and Bioconductor (http://www.bioconductor.org ). For pathway analysis the software PathwayArchitect from Stratagene (La Jolla, CA, USA) was used.
Quantitative real time PCR
An ABI Prism 7700 Sequence Detector (Applied Biosystems, California, USA) was used for mRNA quantification via real-time PCR. Complementary DNA from HGMEC, GEnC cultured at 37°C or from human brain was generated. For human NRGN (assay ID details: Hs00183469) GEnC cDNA was used. Confirmation RT-PCR reactions for the 20 randomly selected transcripts were performed using HGMEC cDNA (List of transcripts and assay ID in Table 2). Beta-actin was used as endogenous control gene (Applied Biosystems, Hs99999903_m1). Normalization of Ct values of each gene (ß-actin and NRGN) and determination of NRGN expression in GEnC cells grown at 37°C was calculated according to the 2 ΔΔCt method [55].
Selection, cloning and sequencing of NRGN
We searched for novel transcripts with the highest potential to be expressed in HGMEC in vivo based on 4 criteria: 1) common to ex vivo glomerulum (which consequently contains non-cultured glomerular endothelial cells) and HGMEC SAGE library; 2) complete absence in the remaining seven nephron segment SAGE libraries namely proximal convoluted tubule, proximal straight tubule, medullary thick ascending limb of Henle's loop, cortical thick ascending limb of Henle's loop, cortical collecting duct, outer medullary collecting duct and distal convoluted tubule containing approximately 350,000 tags [17]; 3) never before shown in EC, 4) enrichment of the transcript in HGMEC: observed expression higher in HGMEC when compared to the non-glomerular endothelial reference library and to the statistically expected count in HGMEC. After NRGN was recognized as the only tag fulfilling these criteria its qRT-PCR product (116 bp) was purified and cloned in a pDrive cloning vector. Minipreps were prepared using the Qiaprep spin Miniprep Kit (Qiagen, Valencia, CA, USA) and vectors containing the insert were selected by EcoRI digestion and sequenced using the M13 reverse primer.
Neurogranin immunofluorescence staining in human kidney sections
For immunofluorescence, 15 μm cryostat sections of human kidney tissue from the fully anonymized archive at the Department of Pathology of the Medical University of Vienna ensuring compliance to the guidelines from the Medical University of Vienna and adherence to The Declaration of Helsinki (see section "Culture of primary HGMEC" above) were fixated and blocked. They were then incubated with 1:500 rabbit anti- NRGN polyclonal or anti-vWF monoclonal antibody for 1 hour. Primary antibodies were visualized using the TSA Plus Kit (PerkinElmer, Wellesley, MA, USA) and photographed with a fluorescence microscope.
Abbreviations
Bp: Base pair; CAV1: Caveolin-1; EC: Endothelial cell; EM: Electron microscopy; GEnC: Glomerular endothelial cell; GEO: Gene expression omnibus; GO: Gene ontology; HGMEC: Human glomerular microvascular endothelial cells; NRGN: Neurogranin; PBS: Phosphate-buffered saline; PCR: Polymerase chain reaction; PECAM1: Platelet/endothelial cell adhesion molecule 1; RT-PCR: Real time polymerase chain reaction; SAGE: Serial analysis of gene expression; SEM: Scanning electron microscopy; TNF: Tumor necrosis factor; VEGF: Vascular growth factor; vWF: Von Willebrand factor.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GS conceived the study, carried out SAGE and finalized the manuscript. WW performed RT-PCR, cloning, sequencing and drafted the manuscript. AK carried out bioinformatics and most statistical analyses. AvH participated in design and interpretation of bioinformatics data as well as in drafting the manuscript. MS wrote the script IdenTag for matching tags from SAGE libraries with public databases. WP and PJ isolated and cultured human glomerular endothelial cells and characterized them by means of immunohistochemistry as well as electron microscopy. AW had set up the initial Access database which included all SAGE libraries and in which merging of tags from different SAGE libraries was accomplished. SB carried out immunohistochemistry for von Willebrand Factor and neurogranin in human kidney sections. GSP participated in the design of the study and drafting the manuscript. All authors read and approved the final manuscript.
Acknowledgements
We gratefully acknowledge skilful technical assistance of Ms. Agnes Perschl and thank Ms. Mathilde Sengoelge and Mr. Andrew Rees for critical reading. GEnC cell line was generously provided by Dr. Simon Satchell and Dr. Peter Mathieson from the University of Bristol. This study was supported by the Austrian Science Fund (FWF) (P16129-B08) as well as the Medical Scientific Fund of the Mayor of the City of Vienna (project number 09038) granted to Guerkan Sengoelge. Arndt von Haeseler acknowledges financial support from the WWTF (Vienna Science Chair in Bioinformatics). Sophia Blake was funded by Long Term Fellowships from EMBO and FEBS.
[1] Auerbach R, Alby L, Morrissey LW, Tu M, Joseph J, Expression of organ-specific antigens on capillary endothelial cellsIn Microvasc Res,1985,29:401-411.
[2] Craig LE, Spelman JP, Strandberg JD, Zink MC, Endothelial cells from diverse tissues exhibit differences in growth and morphologyIn Microvasc Res,1998,55:65-76.
[3] Stan RV, Kubitza M, Palade GE, PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endotheliaIn Proc Natl Acad Sci U S A,1999,96:13203-13207.
[4] Betz J, Bauwens A, Kunsmann L, Bielaszewska M, Mormann M, Humpf HU, Karch H, Friedrich AW, Muthing J, Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cellsIn Biol Chem,2012,393:133-147.
[5] Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO, Endothelial cell diversity revealed by global expression profilingIn Proc Natl Acad Sci U S A,2003,100:10623-10628.
[6] Jorgensen FIn The Ultrastructure of the Normal Human Glomerulus Copenhagen: Munksgaard,1966
[7] de Waard V, van den Berg BM, Veken J, Schultz-Heienbrok R, Pannekoek H, van Zonneveld AJ, Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulusIn Gene,1999,226:1-8.
[8] Amaral MM, Sacerdoti F, Jancic C, Repetto HA, Paton AW, Paton JC, Ibarra C, Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cellsIn PLoS One,2013,8:e70431
[9] Satchell SC, Tasman CH, Singh A, Ni L, Geelen J, von Ruhland CJ, O'Hare MJ, Saleem MA, van den Heuvel LP, Mathieson PW, Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGFIn Kidney Int,2006,69:1633-1640.
[10] Satchell SC, Braet F, Glomerular Endothelial Cell Fenestrations: an Integral Component of the Glomerular Filtration BarrierIn Am J Physiol Renal Physiol,2009,296:947-956.
[11] Foster RR, Armstrong L, Baker S, Wong DW, Wylie EC, Ramnath R, Jenkins R, Singh A, Steadman R, Welsh GI, Mathieson PW, Satchell SC, Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitroIn Am J Pathol,2013,183:604-616.
[12] Velculescu VE, Zhang L, Vogelstein B, Kinzler KW, Serial analysis of gene expressionIn Science,1995,270:484-487.
[13] Boon K, Osorio EC, Greenhut SF, Schaefer CF, Shoemaker J, Polyak K, Morin PJ, Buetow KH, Strausberg RL, De Souza SJ, Riggins GJ, An anatomy of normal and malignant gene expressionIn Proc Natl Acad Sci U S A,2002,99:11287-11292.
[14] Weibel ER, Palade GE, New Cytoplasmic Components In Arterial EndotheliaIn J Cell Biol,1964,23:101-112.
[15] van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA, Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cellsIn Kidney Int,1997,51:1245-1256.
[16] Lu J, Lal A, Merriman B, Nelson S, Riggins G, A comparison of gene expression profiles produced by SAGE, long SAGE, and oligonucleotide chipsIn Genomics,2004,84:631-636.
[17] Chabardes-Garonne D, Mejean A, Aude JC, Cheval L, Di Stefano A, Gaillard MC, Imbert-Teboul M, Wittner M, Balian C, Anthouard V, Robert C, Ségurens B, Wincker P, Weissenbach J, Doucet A, Elalouf JM, A panoramic view of gene expression in the human kidneyIn Proc Natl Acad Sci U S A,2003,100:13710-13715.
[18] Karin M, Gallagher E, TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexesIn Immunol Rev,2009,228:225-240.
[19] Kosodo Y, Suetsugu T, Suda M, Mimori-Kiyosue Y, Toida K, Baba SA, Kimura A, Matsuzaki F, Regulation of interkinetic nuclear migration by cell cycle-coupled active and passive mechanisms in the developing brainIn Embo J,2011,30:1690-1704.
[20] Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A, Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradationIn J Cell Biol,2010,191:615-629.
[21] Nourse MB, Halpin DE, Scatena M, Mortisen DJ, Tulloch NL, Hauch KD, Torok-Storb B, Ratner BD, Pabon L, Murry CE, VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineeringIn Arterioscler Thromb Vasc Biol,2010,30:80-89.
[22] Ibrahim AF, Hedley PE, Cardle L, Kruger W, Marshall DF, Muehlbauer GJ, Waugh R, A comparative analysis of transcript abundance using SAGE and Affymetrix arraysIn Funct Integr Genomics,2005,5:163-174.
[23] Sengoelge G, Luo W, Fine D, Perschl AM, Fierlbeck W, Haririan A, Sorensson J, Rehman TU, Hauser P, Trevick JS, Kulak SC, Wegner B, Ballermann BJ, A SAGE-based comparison between glomerular and aortic endothelial cellsIn Am J Physiol Renal Physiol,2005,288:F1290-F1300.
[24] St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW, Genes expressed in human tumor endotheliumIn Science,2000,289:1197-1202.
[25] Wang CH, Su PT, Du XY, Kuo MW, Lin CY, Yang CC, Chan HS, Chang SJ, Kuo C, Seo K, Leung LL, Chuang YJ, Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formationIn J Cell Physiol,2010,222:685-694.
[26] Costa V, Aprile M, Esposito R, Ciccodicola A, RNA-Seq and human complex diseases: recent accomplishments and future perspectivesIn Eur J Hum Genet,2013,21:134-142.
[27] Wang Z, Gerstein M, Snyder M, RNA-Seq: a revolutionary tool for transcriptomicsIn Nat Rev Genet,2009,10:57-63.
[28] Pleasance ED, Marra MA, Jones SJ, Assessment of SAGE in transcript identificationIn Genome Res,2003,13:1203-1215.
[29] Green DF, Hwang KH, Ryan US, Bourgoignie JJ, Culture of endothelial cells from baboon and human glomeruliIn Kidney Int,1992,41:1506-1516.
[30] Holmen C, Elsheikh E, Christensson M, Liu J, Johansson AS, Qureshi AR, Jalkanen S, Sumitran-Holgersson S, Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosisIn J Am Soc Nephrol,2007,18:2497-2508.
[31] Kniesel U, Wolburg H, Tight junctions of the blood-brain barrierIn Cell Mol Neurobiol,2000,20:57-76.
[32] Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J, Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cellsIn Blood,1997,89:1224-1234.
[33] Nitta K, Uchida K, Yumura W, Nihei H, Characterization of the glomerular endothelial cell in cultureIn Nippon Jinzo Gakkai Shi,1993,35:887-891.
[34] Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO, Endothelial heterogeneity in Shiga toxin receptors and responsesIn J Biol Chem,1993,268:15484-15488.
[35] Ott MJ, Olson JL, Ballermann B, Chronic in vitro flow promotes ultrastructural differentiation of endothelial cellsIn Endothelium,1995,3:21-30.
[36] Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK, Preeclampsia: an endothelial cell disorderIn Am J Obstet Gynecol,1989,161:1200-1204.
[37] Ryan GB, The glomerular sieve and the mechanisms of proteinuriaIn Aust N Z J Med,1981,11:197-206.
[38] Hyink DP, Tucker DC, St John PL, Leardkamolkarn V, Accavitti MA, Abrass CK, Abrahamson DR, Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneysIn Am J Physiol,1996,270:F886-F899.
[39] Ishii M, Hashimoto S, Tsutsumi S, Wada Y, Matsushima K, Kodama T, Aburatani H, Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysisIn Genomics,2000,68:136-143.
[40] Hicke L, Protein regulation by monoubiquitinIn Nat Rev Mol Cell Biol,2001,2:195-201.
[41] Moriyama T, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Horita S, Uchida K, Nitta K, The significance of caveolae in the glomeruli in glomerular diseaseIn J Clin Pathol,2011,64:504-509.
[42] Tati R, Kristoffersson AC, Stahl AL, Morgelin M, Motto D, Satchell S, Mathieson P, Manea-Hedstrom M, Karpman D, Phenotypic expression of ADAMTS13 in glomerular endothelial cellsIn PLoS One,2011,6:e21587
[43] Huang KP, Huang FL, Calcium-sensitive translocation of Calmodulin and Neurogranin between Soma and Dendrites of Mouse Hippocampal CA1 NeuronsIn ACS Chem Neurosci,2011,2:223-230.
[44] Vallortigara J, Alfos S, Micheau J, Higueret P, Enderlin V, T3 administration in adult hypothyroid mice modulates expression of proteins involved in striatal synaptic plasticity and improves motor behaviorIn Neurobiol Dis,2008,31:378-385.
[45] Dong J, Liu W, Wang Y, Xi Q, Chen J, Hypothyroidism following developmental iodine deficiency reduces hippocampal neurogranin, CaMK II and calmodulin and elevates calcineurin in lactational ratsIn Int J Dev Neurosci,2010,28:589-596.
[46] Iniguez MA, Rodriguez-Pena A, Ibarrola N, Aguilera M, Munoz A, Bernal J, Thyroid hormone regulation of RC3, a brain-specific gene encoding a protein kinase-C substrateIn Endocrinology,1993,133:467-473.
[47] Iniguez MA, Rodriguez-Pena A, Ibarrola N, Morreale de Escobar G, Bernal J, Adult rat brain is sensitive to thyroid hormone. Regulation of RC3/neurogranin mRNAIn J Clin Invest,1992,90:554-558.
[48] Sharlin DS, Gilbert ME, Taylor MA, Ferguson DC, Zoeller RT, The nature of the compensatory response to low thyroid hormone in the developing brainIn J Neuroendocrinol,2010,22:153-165.
[49] Kumar J, Gordillo R, Kaskel FJ, Druschel CM, Woroniecki RP, Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidismIn J Pediatr,2009,154:263-266.
[50] Iglesias P, Diez JJ, Thyroid dysfunction and kidney diseaseIn Eur J Endocrinol,2009,160:503-515.
[51] Suher M, Koc E, Ata N, Ensari C, Relation of thyroid disfunction, thyroid autoantibodies, and renal functionIn Ren Fail,2005,27:739-742.
[52] Rodriguez-Gomez I, Sainz J, Wangensteen R, Moreno JM, Duarte J, Osuna A, Vargas F, Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid ratsIn Hypertension,2003,42:220-225.
[53] Rodriguez-Gomez I, Banegas I, Wangensteen R, Quesada A, Jimenez R, Gomez-Morales M, O'Valle F, Duarte J, Vargas F, Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in ratsIn J Endocrinol,2013,216:43-51.
[54] Aydin S, Signorelli S, Lechleitner T, Joannidis M, Pleban C, Perco P, Pfaller W, Jennings P, Influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cellsIn Am J Physiol Cell Physiol,2008,294:C543-C554.
[55] Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodIn Methods,2001,25:402-408.
© 2014 Sengoelge et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.